Argenx
ARGX
#564
Rank
โ‚ฌ32.56 B
Marketcap
535,99ย โ‚ฌ
Share price
-1.73%
Change (1 day)
53.81%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

EPS for Argenx (ARGX)

EPS in 2023 (TTM): -3,87ย โ‚ฌ

According to Argenx 's latest financial reports the company's current EPS (TTM) is -3,84ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -12,10ย โ‚ฌ.

EPS history for Argenx from 2022 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-3,87ย โ‚ฌ-68.05%
2022-12,10ย โ‚ฌ